Most cancers arise in individuals over the age of 60. As the world population is living longer
and reaching older ages, cancer is becoming a substantial public health problem. It is …

The major current conventional types of metastatic breast cancer (MBC) treatments include
surgery, radiation, hormonal therapy, chemotherapy, or immunotherapy. Introducing …

Patients with estrogen receptor (ER)-positive breast cancer are at risk of metastatic relapse
for decades after primary tumor resection and treatment, a consequence of dormant …

Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …

To investigate the effects of age at diagnosis on metastatic breast cancer and patients'
prognosis, we collected patient data from the Surveillance, Epidemiology, and End Results …

Age and tumor subtype are prognostic factors for breast cancer survival, but it is unclear
which matters the most. We used population‐based data to address this question. We …

Purpose To determine the prognostic value of peritumoral edema identified at preoperative
breast magnetic resonance (MR) imaging for disease recurrence in patients with invasive …

Breast cancer is one of the most widespread carcinoma and one of the main causes of
cancer-related death worldwide, especially in women aged between 35 and 75 years …

Background The worldwide incidence of invasive breast cancer in women is increasing
according to several studies. This increase in incidence seems to be higher in young women …

Metastasis is a complex systemic disease that develops as a result of interactions between
tumor cells and their local and distant microenvironments. Local and systemic immune …